Summaries by Inventor VanDussen, Kelli
Intestinal biomarker predicts response to treatment for inflammatory bowel disease
Stappenbeck, Thaddeus ; VanDussen, Kelli
T-019186
Stappenbeck, Thaddeus ; VanDussen, Kelli
T-019186
— Technology Description Researchers in the Stappenbeck lab have discovered an objective histologic biomarker on intestinal cells that can predict a patient’s response to ustekinumab treatment for Crohn’s disease or ulcerative colitis. Specifically, the length of microvilli (MV) could pr…